Array BioPharma (ARRY) PT Raised to $23 at Cowen
Tweet Send to a Friend
Cowen analyst Chris Shibutani raised the price target on Array BioPharma (NASDAQ: ARRY) to $23.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
